The question whether an the invention was obvious was ‘a kind of jury question’. As such, an appellate court should be reluctant to disturb it. If it was so obvious, the patent was invalid.
Judges:
Jenkins LJ
Citations:
(1952) 69 RPC 63
Jurisdiction:
England and Wales
Cited by:
Cited – Biogen Plc v Medeva Plc HL 31-Oct-1996
The claim patented sought to protect a genetic molecule rather than a whole mouse namely that the molecule would, if inserted into a suitable host cell, cause the cell to make antigens of the Hepatitis B virus. A recombinant method of making the . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 21 October 2022; Ref: scu.184325